Elevated levels of angiotensin II have been observed in patients with limited cutaneous SSc [48], which is why angiotensin-converting enzyme (ACE) inhibitors find potential in the treatment of RP [42]. The gene discussed is ACE; the disease is retinitis pigmentosa 1.